Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Determining accurate vancomycin MIC values for methicillin-resistant Staphylococcus aureus by the microdilution method.

Lepe JA, Domínguez-Herrera J, Pachón J, Aznar J.

J Antimicrob Chemother. 2014 Jan;69(1):136-8. doi: 10.1093/jac/dkt308. Epub 2013 Aug 6.

PMID:
23920427
[PubMed - in process]
2.

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method.

Wang JL, Wang JT, Sheng WH, Chen YC, Chang SC.

BMC Infect Dis. 2010 Jun 7;10:159. doi: 10.1186/1471-2334-10-159.

PMID:
20529302
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Correlation of methicillin-resistant Staphylococcus aureus vancomycin minimal inhibitory concentration results by Etest and broth microdilution methods with population analysis profile: lack of Etest overestimation of the MIC.

Khatib R, Riederer K, Shemes S, Musta AC, Szpunar S.

Eur J Clin Microbiol Infect Dis. 2013 Jun;32(6):803-6. doi: 10.1007/s10096-012-1811-7. Epub 2013 Jan 10.

PMID:
23307411
[PubMed - indexed for MEDLINE]
4.
5.

Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients.

Rojas L, Bunsow E, Muñoz P, Cercenado E, Rodríguez-Créixems M, Bouza E.

J Antimicrob Chemother. 2012 Jul;67(7):1760-8. doi: 10.1093/jac/dks128. Epub 2012 May 3.

PMID:
22556382
[PubMed - indexed for MEDLINE]
Free Article
6.

Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey.

Sancak B, Yagci S, Gür D, Gülay Z, Ogunc D, Söyletir G, Yalcin AN, Dündar DO, Topçu AW, Aksit F, Usluer G, Ozakin C, Akalin H, Hayran M, Korten V.

BMC Infect Dis. 2013 Dec 10;13:583. doi: 10.1186/1471-2334-13-583.

PMID:
24325260
[PubMed - in process]
Free PMC Article
7.

Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates.

Pitz AM, Yu F, Hermsen ED, Rupp ME, Fey PD, Olsen KM.

J Clin Microbiol. 2011 Jan;49(1):269-74. doi: 10.1128/JCM.00914-10. Epub 2010 Oct 20.

PMID:
20962147
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Is vancomycin MIC "creep" method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from North East Scotland from 2006 to 2010.

Edwards B, Milne K, Lawes T, Cook I, Robb A, Gould IM.

J Clin Microbiol. 2012 Feb;50(2):318-25. doi: 10.1128/JCM.05520-11. Epub 2011 Nov 30.

PMID:
22135252
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.

Khatib R, Jose J, Musta A, Sharma M, Fakih MG, Johnson LB, Riederer K, Shemes S.

J Antimicrob Chemother. 2011 Jul;66(7):1594-9. doi: 10.1093/jac/dkr169. Epub 2011 Apr 26.

PMID:
21525024
[PubMed - indexed for MEDLINE]
Free Article
10.

Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns.

van Hal SJ, Barbagiannakos T, Jones M, Wehrhahn MC, Mercer J, Chen D, Paterson DL, Gosbell IB.

J Antimicrob Chemother. 2011 Oct;66(10):2284-7. doi: 10.1093/jac/dkr280. Epub 2011 Jul 12.

PMID:
21750101
[PubMed - indexed for MEDLINE]
Free Article
11.

Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.

Alós JI, García-Cañas A, García-Hierro P, Rodríguez-Salvanés F.

J Antimicrob Chemother. 2008 Oct;62(4):773-5. doi: 10.1093/jac/dkn246. Epub 2008 Jun 13.

PMID:
18552338
[PubMed - indexed for MEDLINE]
Free Article
12.

Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation.

Frymoyer A, Hersh AL, Coralic Z, Benet LZ, Joseph Guglielmo B.

Clin Ther. 2010 Mar;32(3):534-42. doi: 10.1016/j.clinthera.2010.03.005.

PMID:
20399990
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The impact of serum vancomycin levels and minimum inhibitory concentrations of methicillin-resistant Staphylococcus aureus on mortality in patients with nosocomial pneumonia.

Machado DP, Goldani LZ, Paiva RM, Aquino VR, de-Paris F, Lisboa T, Jung B, Dos Santos RP.

Can J Infect Dis Med Microbiol. 2013 Fall;24(3):e75-9.

PMID:
24421835
[PubMed]
14.

Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.

Hsu DI, Hidayat LK, Quist R, Hindler J, Karlsson A, Yusof A, Wong-Beringer A.

Int J Antimicrob Agents. 2008 Nov;32(5):378-85. doi: 10.1016/j.ijantimicag.2008.05.007. Epub 2008 Aug 12.

PMID:
18701261
[PubMed - indexed for MEDLINE]
15.

Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus.

Sader HS, Rhomberg PR, Jones RN.

Antimicrob Agents Chemother. 2009 Jul;53(7):3162-5. doi: 10.1128/AAC.00093-09. Epub 2009 Apr 27.

PMID:
19398641
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.

Kullar R, Davis SL, Levine DP, Rybak MJ.

Clin Infect Dis. 2011 Apr 15;52(8):975-81. doi: 10.1093/cid/cir124.

PMID:
21460309
[PubMed - indexed for MEDLINE]
Free Article
17.

Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methods.

Rybak MJ, Vidaillac C, Sader HS, Rhomberg PR, Salimnia H, Briski LE, Wanger A, Jones RN.

J Clin Microbiol. 2013 Jul;51(7):2077-81. doi: 10.1128/JCM.00448-13. Epub 2013 Apr 17.

PMID:
23596249
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureus.

Harigaya Y, Ngo D, Lesse AJ, Huang V, Tsuji BT.

BMC Infect Dis. 2011 Oct 25;11:287. doi: 10.1186/1471-2334-11-287.

PMID:
22026752
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC, Chang SC, Hsueh PR.

J Antimicrob Chemother. 2014 Jan;69(1):211-8. doi: 10.1093/jac/dkt340. Epub 2013 Aug 29.

PMID:
23997017
[PubMed - in process]
20.

Vancomycin Exposure in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: How Much Is Enough?

Lodise TP, Drusano GL, Zasowski E, Dihmess A, Lazariu V, Cosler L, McNutt LA.

Clin Infect Dis. 2014 May 27. pii: ciu398. [Epub ahead of print]

PMID:
24867791
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk